retatrutide phase 3 triumph Top Line results MEGATHREAD : r/Retatrutide retatrutide #obesity #osteoarthritis #clinicaltrials #medicine

Safety considerations in cannabinoid-based medicine

2 Although the number of glucose-lowering agents available to treat T2DM has increased dramatically over the past 10 years, gaps continue to exist in care and outcomes

Its finer gradations make accurate measurement much easier

Gastrointestinal adverse effects of GLP-1 agonistsincluding nausea, vomiting, and dehydrationcould be exacerbated by alcohol use and may complicate medication adherence

1mg dose: 8.7% average weight loss 4mg dose: 15.2% average weight loss 8mg dose: 21.1% average weight loss 12mg dose: 24.2% average weight loss Placebo: 2.1% average weight loss For practical context, a person starting at 220 pounds would lose approximately 53 pounds at the highest dose over 48 weeks

Pergolizzi, The Potential Role of Glucagon-Like Peptide-1 (GLP-1) Agonists for Polycystic Ovary Syndrome